Interra Health has begun supporting the Centers for Medicare & Medicaid Services' GLP-1 Bridge Program, according to Fierce Healthcare. The report, published Thursday, states that the company now backs the federal initiative.
The GLP-1 Bridge Program is tied to CMS, the agency that runs the Medicare and Medicaid programs. GLP-1 refers to a class of medications that has drawn widespread attention in recent years.
Fierce Healthcare's report did not include further details on how Interra Health's support works or what it covers. The available summary offers no information on eligibility, timing or the scope of the company's role.
The item appeared in Fierce Healthcare's news feed on September 10, 2026. No full article text was available beyond the headline and summary.
What to watch next: additional reporting from Fierce Healthcare or CMS for specifics on how the program operates and what Interra Health's participation involves.